William Tolbert

Title: William Tolbert: Innovator in HIV Immunogen Research

Introduction

William Tolbert is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of immunology, particularly in the development of vaccines against HIV. His innovative work focuses on creating stable immunogens that can effectively induce immunity against the Human Immunodeficiency Virus (HIV).

Latest Patents

William Tolbert holds a patent for a "Stable immunogen based on inner domain of HIV-1 gp120 for inducing immunity against HIV." This patent describes stable immunogens that comprise portions of the inner domain of the HIV-1 gp120 protein. These immunogens selectively present the gp120 C1/C2 region in its CD4-bound state within a minimal structure. The immunogens can be utilized to vaccinate subjects against HIV infection, which is the causative agent of Acquired Immunodeficiency Syndrome (AIDS). Additionally, these immunogens can serve as targets in screening to identify small molecule or peptide inhibitors that block HIV-1 viral entry and attachment steps. They can also be used as probes for identifying gp120 C1/C2 region-specific antibodies.

Career Highlights

William Tolbert is affiliated with the University System of Maryland, where he conducts his research and development work. His career is marked by a commitment to advancing the understanding and treatment of HIV through innovative scientific approaches.

Collaborations

Some of his notable coworkers include Marzena Pazgier and George K Lewis, who contribute to the collaborative efforts in his research endeavors.

Conclusion

William Tolbert's work in developing stable immunogens represents a significant advancement in the fight against HIV. His innovative contributions continue to pave the way for new vaccine strategies and therapeutic approaches.